title: Mass spectrometric determination of IgG subclass-specific glycosylation profiles in siblings discordant for myositis syndromes.
abstract: Many autoimmune conditions are believed to result from chronic inflammation as a consequence of the interaction of genetic and environmental factors in susceptible individuals. One common feature in some autoimmune diseases is the decrease in terminal galactosylation of the constant region N-glycan of the total plasma immunoglobulin. To determine whether a similar pattern is characteristic for the autoimmune disorder myositis, we analyzed the antibody subclass specific glycosylation in patients with myositis, their asymptomatic siblings, and healthy unrelated age- and sex-matched controls. The antibody subclass specific glycosylation was determined from the LC-MS analyses of the IgG glycopeptides generated by trypsin digestion of the antibody heavy chain. The glycosylation profiles of the IgG subclasses were determined relative to the total abundance of all glycoforms. We found elevated amounts of glycoforms lacking terminal galactose in myositis patients. Pairwise statistical analyses reveals that galactosylation is statistically different between the myositis patients and control groups. Furthermore, the trend analysis for glycosylation indicates a pattern of decreasing galactosylation in the order controls ≥ siblings ≥ myositis patients, suggesting the existence of a genetic, immune-related predisposition in the group of asymptomatic siblings that can be detected before the onset of clinical symptoms at the level of plasma proteins.
authors: Laboratory of Structural Biology, NIH/DHHS, Research Triangle Park, North Carolina 27709, USA.
authors: Irina
authors: I
authors: Perdivara
authors: Shyamal D
authors: SD
authors: Peddada
authors: Frederick W
authors: FW
authors: Miller
authors: Kenneth B
authors: KB
authors: Tomer
authors: Leesa J
authors: LJ
authors: Deterding
references: Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6758-63
references: 17412832
references: Int J Rheum Dis. 2010 May;13(2):117-24
references: 20536595
references: J Rheumatol. 2000 Jun;27(6):1379-85
references: 10852257
references: Glycoconj J. 2002 Jan;19(1):23-31
references: 12652077
references: Genes Immun. 2009 Jul;10(5):373-9
references: 19440199
references: Clin Exp Immunol. 2010 May;160(2):161-7
references: 20041883
references: Arthritis Rheum. 1990 Sep;33(9):1361-70
references: 2403400
references: Ann Rheum Dis. 2010 Jan;69 Suppl 1:i92-96
references: 19995755
references: Proteomics. 2007 Nov;7(22):4070-81
references: 17994628
references: Autoimmun Rev. 2009 Sep;9(1):58-61
references: 19285154
references: Glycobiology. 2003 Jul;13(7):41R-53R
references: 12651883
references: J Rheumatol. 2000 Jan;27(1):26-34
references: 10648014
references: Protein Sci. 1993 Feb;2(2):183-96
references: 7680267
references: Eur J Clin Invest. 1999 May;29(5):413-25
references: 10354198
references: J Clin Invest. 1990 Feb;85(2):468-75
references: 1688885
references: Anal Chem. 1993 Apr 1;65(7):877-84
references: 8470819
references: J Autoimmun. 1991 Oct;4(5):779-94
references: 1797027
references: Nature. 1985 Aug 1-7;316(6027):452-7
references: 3927174
references: Anal Bioanal Chem. 2008 May;391(1):325-36
references: 18369607
references: Dis Markers. 2008;25(4-5):267-78
references: 19126970
references: Arthritis Res Ther. 2009;11(6):R193
references: 20015375
references: Diabetes Care. 2006 Mar;29(3):662-7
references: 16505523
references: Bioinformatics. 2003 May 1;19(7):834-41
references: 12724293
references: J Rheumatol. 2003 Dec;30(12):2540-6
references: 14719191
references: Proc Natl Acad Sci U S A. 2005 Jul 26;102(30):10604-9
references: 16009939
references: Nat Genet. 2009 Feb;41(2):240-5
references: 19151718
references: Science. 2006 Aug 4;313(5787):627-8
references: 16888131
references: Rheum Dis Clin North Am. 2002 Nov;28(4):723-41
references: 12510664
references: Rheumatology (Oxford). 2001 Nov;40(11):1262-73
references: 11709610
references: Science. 2008 Apr 18;320(5874):373-6
references: 18420934
references: Glycobiology. 2005 Sep;15(9):827-37
references: 15858074
references: Arthritis Rheum. 2008 Oct;58(10):3239-46
references: 18821675
references: Bioinformatics. 2005 Oct 15;21(20):3933-4
references: 16109745
references: N Engl J Med. 1975 Feb 13;292(7):344-7
references: 1090839
references: Science. 2006 Aug 4;313(5787):670-3
references: 16888140
references: Proc Natl Acad Sci U S A. 1990 Dec;87(24):9933-7
references: 1702223
references: Proc Natl Acad Sci U S A. 2007 May 15;104(20):8433-7
references: 17485663
references: Genome Res. 2010 Feb;20(2):170-9
references: 20028698
references: Autoimmunity. 2004 Jun;37(4):291-4
references: 15518044
references: Curr Rheumatol Rep. 2002 Oct;4(5):434-41
references: 12217249
references: J Am Soc Mass Spectrom. 2008 Mar;19(3):428-44
references: 18187336
references: Biometrics. 2004 Sep;60(3):661-9
references: 15339288
references: N Engl J Med. 1991 Nov 21;325(21):1487-98
references: 1658649
references: Arthritis Rheum. 2005 Sep;52(9):2607-15
references: 16142757
references: Glycobiology. 2010 Aug;20(8):959-69
references: 20356825
references: Proteomics. 2009 Feb;9(4):882-913
references: 19212958
references: Medicine (Baltimore). 1991 Nov;70(6):360-74
references: 1659647
references: Lancet. 2003 Nov 22;362(9397):1762-3; author reply 1763
references: 14643132
references: Hum Mol Genet. 2005 May 15;14(10):1305-14
references: 15814587
references: Mol Biosyst. 2010 Feb;6(2):329-35
references: 20094651
references: Glycobiology. 2009 Sep;19(9):958-70
references: 19318519
references: J Proteome Res. 2009 Feb;8(2):631-42
references: 19093876
references: Immunol Lett. 2006 Aug 15;106(2):103-10
references: 16814399